Current status of adjuvant endocrine therapy for premenopausal patients with primary breast cancer

被引:0
|
作者
A Howell
机构
[1] University of Manchester,CRUK Department of Medical Oncology
[2] Christie Hospital NHS Foundation Trust,undefined
来源
Breast Cancer Research | / 9卷
关键词
Breast Cancer; Tamoxifen; Young Woman; Endocrine Therapy; Aromatase Inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] New developments in endocrine therapy of premenopausal breast cancer
    Bauerschlag, D. O.
    Crohns, C.
    Heindrichs, U.
    Meinhold-Heerlein, I
    Maass, N.
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2010, 8 (01): : 26 - 29
  • [22] Adjuvant Endocrine Treatment in Premenopausal Early Breast Cancer
    Orlando, L.
    Fedele, P.
    Cinefra, M.
    Sponziello, F.
    Calvani, N.
    Chetri, M. C.
    Rizzo, P.
    D'Amico, M.
    Schiavone, P.
    Portaluri, M.
    Criscuolo, M.
    Burlizzi, S.
    Cinieri, S.
    ONCOLOGY, 2009, 77 : 9 - 13
  • [23] Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions
    Goss, Paul E.
    Muss, Hyman B.
    Ingle, James N.
    Whelan, Timothy J.
    Wu, Melinda
    CLINICAL BREAST CANCER, 2008, 8 (05) : 411 - 417
  • [24] Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
    Villarreal-Garza, Cynthia
    Mesa-Chavez, Fernanda
    Ferrigno, Ana S.
    Garza-Ramos, Cynthia De la
    Fonseca, Alan
    Villanueva-Tamez, Karen
    Campos-Salgado, Jose Y.
    Cruz-Ramos, Marlid
    Rodriguez-Gomez, David O.
    Ruiz-Cruz, Sandy
    Cabrera-Galeana, Paula
    BREAST, 2021, 59 : 8 - 15
  • [25] Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
    Rosso, Roberta
    D'Alonzo, Marta
    Bounous, Valentina Elisabetta
    Actis, Silvia
    Cipullo, Isabella
    Salerno, Elena
    Biglia, Nicoletta
    CURRENT ONCOLOGY, 2023, 30 (02) : 1461 - 1472
  • [26] Extended Adjuvant Endocrine Therapy in Early Breast Cancer Patients-Review and Perspectives
    Bekes, Inga
    Huober, Jens
    CANCERS, 2023, 15 (16)
  • [27] Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer
    Lemij, Annelieke A.
    de Glas, Nienke A.
    Derks, Marloes G. M.
    Bastiaannet, Esther
    Merkus, Jos W. S.
    Lans, Titia E.
    van der Pol, Carmen C.
    van Dalen, Thijs
    Vulink, Annelie J. E.
    van Gerven, Leander
    Guicherit, Onno R.
    Linthorst-Niers, Eugenie M. H.
    van den Bos, Frederiek
    Kroep, Judith R.
    Liefers, Gerrit Jan
    Portielje, Johanneke E. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 193 (03) : 567 - 577
  • [28] Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement
    Gao, Pin
    You, Lili
    Wu, Di
    Shi, Aiping
    Miao, Qing
    Rana, Ujala
    Martin, Dustin Paul
    Du, Ye
    Zhao, Gang
    Han, Bing
    Zheng, Chao
    Fan, Zhimin
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 887 - 897
  • [29] Current advances in endocrine therapy options for premenopausal women with hormone receptor positive breast cancer
    Gemignani, Mary L.
    Hetzel, David J.
    GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 153 - 157
  • [30] Concurrent administration of ovarian function suppression and adjuvant endocrine treatment for premenopausal early breast cancer
    Ding, Jinhua
    Jiang, Li
    Wu, Weizhu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 2036 - 2044